Oxford Global’s Pharmaceutical IT Congress: All 38 speakers male! (it seems)
http://t.co/ctu18mKLAw
@phylogenomics @GenderAvenger #YAMMM
— Elisabeth Bik (@MicrobiomDigest) May 13, 2015
I figured even in an era of blatant sexism in science, this must be a mistake right? How could there be a conference with 38 male speakers and 0 female speakers. So I went to the site: Who is Speaking – Oxford Global's 13th Pharmaceutical IT Congress, September 2015. And, well, as far as I can tell Elisabeth Bik has the numbers right. (See a list at the end of this post). They even have a running slideshow of the speakers faces.This is even worse than the 25:1 ratio of the qBio meeting I lost it over a few years ago. I have never seen anything like this. I note - a 38:0 ratio is nearly impossible by chance in any field and I think pretty clearly an indication of massive bias of some kind.
Oxford Global Sequencing Meetings: Where MEN Tell You About Sequencing #YAMMM
I think it is time to just boycott meetings meetings from Oxford Global. The only way they will change is if people stop speaking at or going to their meetings. So please - stop going to their meetings. Stop speaking at their meetings.
Speakers 2015:
- Sebastien Lefebvre
Director Data Engineering and Technology – Global Data Office, Biogen Idec - Uwe Barlage
EDC Project Leader, Bayer Healthcare - Marc Berger
Vice President, Real World Data and Analytics, Pfizer - Michael Braxenthaler
Pharma Research and Early Development Informatics, Global Head Strategic Alliances, Roche, & President, Pistoia Alliance - Arnaub Chatterjee
Associate Director - Data Science, Insights and Partnerships, Merck - James Connelly
Global Head, Research Data Management, Sanofi - Jos Echelpoels
Director IT, Regional Initiatives, Janssen - Brian Ellerman
Head of Technology Scouting and Information Science Innovation, Sanofi - Peter Elsig Raun
Director & Head Business Analysis, Lundbeck - Dimitrios Georgiopoulos
Chief Scientific Officer UK, Novartis - Charles Gerrits
Vice President, Innovative Patient-Centric Endpoints and Solutions, Sanofi - Yike Guo
Professor of Computing Science, Imperial College London and Chief Technology Officer, tranSMART Foundation - Sergio H. Rotstein
Director, Research Business Technology, Pfizer - Juergen Hammer
Global Head Data Science, Center Head Pharma Research and Early Development Informatics, Roche - Jan Hauss
Head Central Analytics Informatics, Merck - Athula Herath
Statistical Director, Translational Sciences, MedImmune - Nigel Hughes
Director Integrative Healthcare Informatics, Janssen Research and Development - Michael Hvalsøe Brinkløv
BI Architect, IT Platforms & Infrastructure, Lundbeck - Robert J. Boland
Senior Manager, Translational Informatics & External Innovation R&D IT, Janssen - Adrian Jones
Associate Director, Business Intelligence Systems, Astellas - Srivatsan Krishnan
Director and Head of R&D Operations and IT, Bristol-Myers Squibb - Philippe Marc
Global Head of Preclinical Informatics, Novartis Institutes for Biomedical Research - Dermot McCaul
Director, Preclinical Development and Biologics IT, Merck - Pantaleo Nacci
Head Statistical Safety & Epidemiology/PV, Novartis Vaccine and Diagnostics Srl (a GSK company) - Gerhard Noelken
Global Business IT Lead for Pharmaceutical Science, Pfizer WRD - Emmanuel Pham
VP Biométrie, Ipsen - Andrew Porter
Director, Enterprise Architecture, Merck - Gabriele Ricci
Vice President of TechOpps IT, Shire - Anthony Rowe
Director, Translational Informatics and External Innovation, Johnson & Johnson - Martin Ryzl
Director, GIC Analytics Platform Engineering, Merck - Wolfgang Seemann
Senior Project Manager, Bayer Business Services - Aziz Sheikh
Professor of Primary Care Research & Development and Co-Director Center for Population Health Sciences, The University of Edinburgh - Yan Song
Associate Director, Bioanalysis Operations, AbbVie - Devry Spreitzer
Director, Global Electronic Systems Quality Assurance, Astellas - Jason Swift
Head R&D Information UK, AstraZeneca - Kevin Teburi
Director – iMed Team Leader, R&D Information, AstraZeneca - Simon Thornber
Director, Data Analytics, Informatics and Innovation, GlaxoSmithKline - Tjeerd Van Staa
Professor of Health eResearch, University of Manchester
Some past meetings from Oxford Global to consider
http://www.bmsystems.net/download/BioMarkers-BMsystems-conferenceprogramme.pdf
https://web.archive.org/web/20120514151415/http://www.ngsasia-congress.com/
I don’t think that you should take this in this context. Though I am a small time event planner but I have organized meetings where meeting room was full of males only. It’s not something new in my opinion as I get to face it every other day.
ReplyDelete